INTRODUCTION
Vitamins are organic nutrients required in small quantities for a variety of essential biochemical functions. Vitamins are not usually synthesized by the body so must be supplied in the diet 1 . Concern has existed for some time over the possibility that chronic hemodialysis patients are at high risk for the development of vitamin deficiencies because diets prescribed for kidney disease patients tend to be low in certain vitamins 2 , the dialysis procedure may result in clearance of vitamins from blood 2, 3 , metabolites that accumulate in the uremic milieu may impair the proper utilization of vitamins 2, 3 , spontaneous reductions in food intake due to uremia may lead to inadequate vitamin consumption 3 , and medications and/or illnesses common to hemodialysis patients may interfere with the absorption and/or activity of vitamins [2] [3] [4] .
Because of such concerns hemodialysis patients in the U.S. are routinely prescribed multivitamin supplements. In fact, over 70% of U.S. hemodialysis patients take such supplements, a far greater proportion than in other developed nations 5 . Such a policy is officially promoted by large U.S. dialysis providers 6, 7 and nonprofit institutions 8, 9 . Yet the implications of this policy must be carefully considered. While the total cost of hemodialysis vitamin supplementation in the U.S. is not available and probably accounts for a very small proportion of overall dialysis costs, it is likely to be in the many millions of dollars annually given the sizeable numbers of patients and available pricing [10] [11] [12] . In addition, vitamin supplementation increases the already large pill burden hemodialysis patients must contend with. Furthermore, in light of previous reports the possibility that vitamin supplementation may actually have harmful effects should be considered [13] [14] [15] [16] .
Finally, US government-mandated fortification of foodstuffs may also mitigate the need to supplement certain vitamins.
In light of questions about the potential benefits and drawbacks of vitamin supplementation and whether vitamin supplementation is beneficial, we performed a systematic review of the medical literature to evaluate the evidence for routine vitamin supplementation in the U.S. adult chronic intermittent hemodialysis population. In this article we present the evidence for supplementing each individual vitamin. We chose to focus exclusively on U.S. hemodialysis patients, the largest such population of any nationality, because their vitamin requirements may be unique in light of their food preferences and the specific pattern of vitamin fortification in U.S. foodstuffs.
Systematic Review
We limited our search to humans and the English language using the Ovid Medline database between 1970 and 2014 and search terms vitamins, avitaminosis, and dietary supplements and subheadings renal dialysis, hemofiltration, and hemodialysis. From this database we used the separate terms of vitamin A, ascorbic acid, vitamin D, vitamin E, vitamin K, thiamine, riboflavin, niacinamide, vitamin B6, vitamin B12, biotin, folic acid and pantothenic acid. Of the 1076 articles that were identified, we then focused primarily on studies of adult hemodialysis patients within the U.S., though we did examine and occasionally include data from other hemodialysis populations, especially if the literature was sparse on the topic. We did not limit our initial search by patient age or location or 6 study design because of concerns about the paucity of published data on this topic and wanted to be certain to capture all relevant information prior to excluding any studies.
What Defines Adequate Nutritional Intake?
Adequacy of body content and functional activity of vitamins has been determined traditionally by assessing dietary intake, corresponding biochemical values--usually from serum or plasma or red blood cells, though occasionally in urine, and in enzyme activities--and other biological processes or clinical manifestations of deficiency or excess. For example, the effects of certain vitamins on hemoglobin production or plasma and urinary oxalate levels may be indicators of deficiency or excess. Though not ideal, the best available objective indicator of adequate vitamin intake is blood levels because correlating vitamin intake with illness has been much more elusive. We will therefore use blood vitamin content as the basis of determining the need for vitamin supplementation.
Dietary reference intakes (DRI) are a set of reference values that help establish daily nutrient intake recommendations and are therefore a standard by which the adequacy of nutrient intake can be assessed 17 . While DRIs can be used as general benchmarks, extrapolating such benchmarks to patients with CKD or other illnesses in which they
have not been carefully studied should be done with caution. 
Current Recommendations on Dialysis Multivitamins
The 2005 Kidney Disease Outcome Quality Initiative (KDOQI) guidelines state that "…it is prudent to supplement, rather than risk deficiency, especially when supplementation is safe at the recommended levels. Therefore, dialysis patients are likely to benefit from daily vitamin supplementation that provides the recommended published vitamin profile for dialysis patients, with special attention…" given to B vitamins and folic acid 18 .
Similar recommendations exist for children with chronic kidney disease, though this topic is not covered in this review 19 . Kidney Disease Improving Global Outcomes (KDIGO) recommends only that patients with an elevated PTH be started on calcitriol or a vitamin D analog and that vitamin D deficiency be excluded and treated using the strategy for the general population 20 . These recommendations are endorsed by the European Renal Best Practice (ERBP) guidelines 21 .
WATER SOLUBLE VITAMINS Vitamin B1 (Thiamine)
Thiamine is a cofactor for many enzymes involved in carbohydrate metabolism and neural function 22 . Foods rich in thiamine include pork, legumes, beef, nuts, whole grains, and organ meat 23 though for decades flour has been enriched with thiamine in the U.S.
Thiamine deficiency can result in beriberi and subsequent heart failure and peripheral neuritis 24 .
Evidence for Altered Requirements in Hemodialysis Patients
Dialysis patients are theoretically at risk for thiamine deficiency because of poor nutritional intake and loss of water-soluble vitamins in the hemodialysis effluent 24 .
However, studies examining thiamine blood content in hemodialysis patients report equivocal findings. In the only study of U.S. patients, Ramirez et al demonstrated in the mid-1980s that 15 hemodialysis patients who were taken off their B vitamin supplementation were able to maintain normal thiamine blood levels over a six-month period. In five of those patients they measured thiamine directly pre-and post-HD and noted no significant change 25 . A subsequent study reported normal thiamine blood levels (mean 162 ± 42 ng/ml; normal range: 92-224 mg/ml) in twenty German patients not on supplementation who had been on hemodialysis for a median of 24 months 26 .
In contrast, several reports of modest size have described low thiamine blood levels in hemodialysis patients 24, [27] [28] [29] . Two of them-from Taiwan and Japan-reported an association between low thiamine levels and confusion or encephalopathy 24, 27 , with one of them describing an unusually high prevalence (33%) of Wernicke Encephalopathy.
An additional study in patients in an intensive care unit setting found that the initiation of continuous renal replacement therapy was associated with an acute but nonstatistically significant drop in plasma erythrocyte thiamine levels (382 ± 109 to 264 ± 136 nmol/L) over eight hours, though levels remained within the normal range (100-300nmol/L)
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The lack of long term, contemporary data makes it difficult to assess the rate or risk of thiamine deficiency in U.S. hemodialysis patients. Further complicating data interpretation is differences between nations in thiamine enrichment in flour and grains and their consumption. It is not surprising that the reports of Wernicke Encephalopathy described above originated in Asian countries, where a combination of low thiamine enrichment 31 and high carbohydrate consumption make this presentation more likely 22 .
One would reasonably expect a much lower risk of thiamine deficiency--even among hemodialysis patients--in nations such as the U.S., which has very high levels of enrichment and consumption of flour products.
Vitamin B2 (Riboflavin)
Riboflavin is a hydrophilic B vitamin that is part of the moiety of flavin adenine dinucleotide (FAD) and flavin mononucleotide (FMN) that comprise flavoenzymes. Its function involves metabolism of fats, carbohydrates and proteins 23 . Riboflavin is found in milk and dairy products, meat, fish, eggs and broccoli. In the U.S. breads and cereals have been enriched with riboflavin since the 1940s 23 . Riboflavin deficiency is not fatal due to very efficient tissue conservation 1 and is characterized by nonspecific symptoms and signs, though more advanced deficiency may involve cheilosis, desquamation and inflammation of the tongue, seborrheic dermatitis, and microcytic anemia 22 .
Evidence for Altered Requirements in Hemodialysis Patients
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There are currently no studies of riboflavin status in U.S. or other hemodialysis populations. We expect that deficiency is less likely to occur in U.S. hemodialysis patients because of longstanding enrichment of foodstuffs with riboflavin.
Vitamin B3 (Niacin)
Niacin, ingested as either nicotinamide (from animal sources) or nicotinic acid (from plants), becomes active in vivo when converted to cofactors used for oxidative processes 22 . Rich sources of niacin include baker's yeast, animal and dairy products, cereals, legumes, and leafy green vegetables 22 . Niacin can also be synthesized from the amino acid tryptophan. Niacin deficiency leads to pellagra, characterized by the "4 Ds":
dermatitis, diarrhea, dementia, and death. Pellagra is typically observed with intakes deficient in niacin and tryptophan, such as maize-based diets 22 .
Evidence for Altered Requirements in Hemodialysis Patients
Fifteen American hemodialysis patients dialyzed using parallel-plate dialyzers were able to sustain normal niacin levels for 6 months after being taken off vitamin supplementation 25 . An additional study in Japanese patients on hemodialysis for a mean of 7 years found mean blood nicotinamide adenine dinucleotide (NAD) levels to be no different from controls not on hemodialysis 32 . There is inadequate data to definitively assess the risk of niacin deficiency in U.S. hemodialysis patients, but current fortification of foodstuffs with niacin makes it less likely to occur.
Vitamin B5 (Pantothenic Acid)
Pantothenic acid is used to synthesize Coenzyme A (CoA), a critical factor in many metabolic processes including fatty acid oxidation, protein transport, and the formation of acetyl CoA, a key molecule in energy metabolism 23 . Although pantothenic acid appears to be ubiquitous in the food supply, whole grains, vegetables, liver, and egg yolks are especially rich sources 23 . Deficiency has not been clearly identified in humans except in specific depletion studies.
Evidence for Altered Requirements in Hemodialysis Patients
No data exists on this topic.
Vitamin B6 (Pyridoxine)
Vitamin B6 exists in vivo in several forms: pyridoxal, pyridoxine, pyridoxamine, and the 5' phosphates of these compounds. Pyridoxal-5-phosphate (PLP) is a cofactor for many enzymes, particularly those involving amino acid metabolism, and is necessary for heme synthesis 3 . Vitamin B6 is generally abundant in foods but especially rich sources include meats, whole grain products, vegetables, and nuts 22 . Severe vitamin B6 deficiency may lead to peripheral neuropathy, convulsions, dermatitis, abnormal electrocardiogram findings, depression, confusion and due to its involvement with hemoglobin synthesis, microcytic anemia 22, 23 . Interestingly, sensory neuropathy has been reported in patients taking daily doses of B6 as low as 200 mg, with residual damage remaining after stopping supplementation 1 . 
Evidence for Altered Requirements in Hemodialysis Patients
Vitamin B7 (Biotin)
Biotin helps mediate carboxylation and cell cycle regulation by biotinylating key nuclear proteins 1 . Biotin is widely distributed in many foods as biocytin (-amino-biotinyllysine), which is released with proteolysis. It is also synthesized by intestinal flora in excess of 13 requirements 1 . Though deficiency is rare it can occur with prolonged total parental nutrition or massive consumption of egg white, which contains avidin, which binds biotin in the intestine. Deficiency results in mental status changes, paresthesias, and nausea 23 .
Evidence for Altered Requirements in Hemodialysis Patients
There are no studies of biotin status in US hemodialysis patients. In a study by Oguma et al, 27 Japanese HD patients found that biotin levels were significantly higher than controls, but the assay used may have been measuring biotin and its metabolites 40 .
Vitamin B9 (Folic Acid)
Folic acid transports single carbons or methyl groups to help synthesize nucleotides needed for cell division and growth 22 . It is also needed for the metabolism of several amino acids 3 . Food sources rich in folic acid include leafy green vegetables, fruit, yeast, and liver 22 . Nationwide fortification of cereal grains in the United States and Canada began in 1996 41 . Deficiency results in megaloblastic anemia and neural tube defects. Of note, initial support for supplementing hemodialysis patients with folic acid, vitamin B6, and vitamin B12 was partly related to their ability to lower the putative atherothrombotic risk factor plasma homocysteine. The rationale for such a strategy has dissipated now that homocysteine lowering has been demonstrated not to have cardioprotective effects 42 .
Evidence for Altered Requirements in Hemodialysis Patients
While the risk of folic acid deficiency may be higher in HD patients because leafy green vegetables tend to be restricted due to high potassium content, this is likely offset by the fortification of grains and cereals in the U.S. 43 A series of older and contemporary U.S. studies including many hundreds of patients, pre-and post-fortification, report that folate levels are well maintained in chronic hemodialysis patients 25, 38, 39, [44] [45] [46] . Based on the available evidence, it appears that folic acid deficiency is very uncommon among U.S. chronic hemodialysis patients.
Vitamin B12 (Cyanocobalamin)
Vitamin B12 plays a major role in the methylation cycle and is a cofactor in the synthesis of the amino acid methionine 22 . Major food sources are those of animal origin like eggs, liver, beef, chicken and salmon because with rare exception it is only synthesized by bacteria found in higher predatory organisms and not plant foods 1 . Vitamin B12 is also found in fortified foods like breakfast cereals 3 . Vitamin B12 deficiency causes a functional folate and methionine deficiency leading to megaloblastic anemia and irreversible degeneration of the spinal cord (i.e. pernicious anemia) 1 . Vitamin B12 can be measured directly in serum or plasma, though methylmalonic acid levels is a more specific and sometimes more sensitive indicator of vitamin B12 deficiency 22 .
Evidence for Altered Requirements in Hemodialysis Patients
In a study of fifteen U.S. hemodialysis patients, B12 levels remained in the normal range during a six-month study period despite not taking B vitamin supplementation 25 .
Multiple additional studies have demonstrated that U.S. hemodialysis patients have normal B12 levels 38, 39, 45, 46 and are not at high risk of vitamin B12 deficiency.
Vitamin C (Ascorbic Acid)
While the main function of Vitamin C is to maintain collagen function, it also acts as an electron donor and cofactor in the production of catecholamines, many peptide hormones, osteocalcin, C1q (part of the complement cascade), protein C, and carnitine 1, 22 . Major sources include green vegetables, citrus fruits, potatoes and tomatoes 23 . Vitamin C deficiency causes scurvy which manifests as tooth loss, gum decay, fragility of capillaries, bone fractures and skin changes 1 .
Evidence for Altered Requirements in Hemodialysis Patients
Achieving optimal vitamin C status is a challenge in hemodialysis patients. Renal dietary restrictions imposed on such patients make it more likely they will avoid foods with high vitamin C content. Additionally, vitamin C is cleared during standard hemodialysis sessions [47] [48] [49] . However, vitamin C supplementation contributes to a rise in oxalate 47 which can deposit in tissues and lead to bone disease, arthropathies, vascular calcification, skin deposits, and liver failure 50 .
The only study in U.S. patients was performed over twenty years ago and demonstrated that white and black hemodialysis patients-most of whom took a daily vitamin Ccontaining multivitamin--had similar and normal mean vitamin C plasma concentrations 51 . Several other reports from Europe and Asia report a relatively high prevalence of vitamin C deficiency, though the whether this led to detrimental effects was not well described 47, 48, [52] [53] [54] . Oral and/or intravenous vitamin C supplementation have been shown in hemodialysis patients to increase vitamin C blood levels with relative ease 47, 48, 53, 54 .
The available medical literature is not helpful in ascertaining the risk of vitamin C deficiency in US hemodialysis patients, though theoretical concerns cited above remain.
This must be balanced by contrary concerns about oxalate deposition and end-organ damage from vitamin C supplementation and the lack of reports of vitamin C deficiency in countries that do not use vitamin supplementation.
FAT SOLUBLE VITAMINS Vitamin A
Vitamin A plays an important role in the proper function of the visual and immune system, cell differentiation, and cell turnover 1, 22 . Carotenoids, which are precursors to vitamin A, are abundant in dark green and deeply colored fruits and vegetables 23 , while preformed vitamin A is present in animal source foods like liver, fish, and eggs 22 .
Vitamin A deficiency results in night blindness and xerophthalmia and is the leading cause of preventable blindness in children 22 . It also decreases normal function of vitamin D and increases susceptibility to infection 1 by compromising the innate and acquired immune system 23 .
Evidence for Altered Requirements in Hemodialysis Patients
While there are no studies of vitamin A in the U.S. hemodialysis population, studies from
Europe and Australia [55] [56] [57] [58] [59] reported that vitamin A levels in chronic hemodialysis patients were generally within the normal range and frequently at least as high, if not higher, than healthy controls.
Vitamin E
Vitamin E influences the fluidity of cell membranes and prevents oxidative damage by reacting with lipid peroxide radicals 1 . Because vitamin E is widely dispersed in foods and oils deficiency is uncommon though can occur with diseases like cystic fibrosis or other diseases associated with fat malabsorption 23 . Vitamin E deficiency is associated with nerve and muscle damage, opthalmoplegia, pigmented retinopathy and hemolytic anemia 1, 23 .
Evidence for Altered Requirements in Hemodialysis Patients
A recent study of eleven U.S. hemodialysis patients found that baseline levels were within the normal range and increased significantly with vitamin E supplementation 60 .
These findings have been replicated in several other studies performed outside the US 55, 57, 61, 62 , though not all concur 58 .
Vitamin K
Vitamin K is a critical cofactor for the clotting system and nervous system development 1 .
Vitamin K is found in two forms: phylloquinone (PK) (vitamin K1), found in green leafy vegetables and animal products, and menaquinone (MK) (vitamin K2), which is synthesized by intestinal bacteria. Sources of vitamin K include kale, spinach, liver, margarine, vegetable oils, and soybean oils 23 . Vitamin K deficiency is caused by low dietary intake, chronic liver disease, and conditions that alter intestinal flora or fat content of bile salts. Prolonged prothrombin time is the most common and earliest finding of deficiency and is associated with increased bleeding risk from inactivation of vitamin Kdependent clotting factors 23 .
Evidence for Altered Requirements in Hemodialysis Patients
There are no studies of vitamin K in US hemodialysis patients. Several European studies reported that mean vitamin K levels of hemodialysis patients were normal [63] [64] [65] , though a minority of subjects did have low levels 65 , as did subjects in a separate study that indirectly measured vitamin K status as reflected in protein carboxylation 66 . leading to rickets in children and osteomalacia in adults 1 .
Kidney failure is known to lead to inadequate production of calcitriol and secondary hyperparathyroidism, which is why calcitriol or its analogues are routinely supplemented in hemodialysis patients. 
ASSESSMENT OF THE LITERATURE AND RECOMMENDATIONS
Hemodialysis patients are prescribed multivitamins for an increased theoretical risk of (primarily water soluble) vitamin deficiencies. As our review indicates, the available information does not strongly support routine water-soluble vitamin supplementation.
With regard to fat-soluble vitamins, only vitamin D has been consistently demonstrated to be low in a significant segment of U.S. hemodialysis patients, and a daily multivitamin therapy is not appropriate treatment for this deficiency because supplementation recommendations require much higher doses.
In light of our findings we advise against a blanket recommendation to supplement all hemodialysis patients and recommend instead that supplementation be individualized based on clinical judgment and necessity. Reasons include the lack of supportive evidence as well as the associated inconvenience, cost, and possibly even hazards of 20 consuming a daily dialysis vitamin. The latter concern is rarely cited but should not be ignored. There is epidemiologic and clinical trial data supporting an increased risk of cardiovascular events in men taking supplemental calcium 13 , of advanced and fatal prostate cancers in healthy men 14 and transaminitis in HIV patients 16 with multivitamin use, and of mortality in lung cancer patients taking beta carotene and vitamin A 15 . Apart from the risks, the literature is littered with negative clinical trials studying multivitamins [71] [72] [73] [74] [75] [76] . Thus, we should not automatically assume that multivitamin therapy is not without risks. Rather, primum non nocere should be our code of action.
Of note, a recent epidemiologic analysis from the international Dialysis Outcomes and Practice Patterns Study (DOPPS) 77 observed that greater use of water soluble vitamin supplementation was associated with lower mortality rates. We would urge caution in accepting this finding in light of the study's limitations, which include lack of face-toface confirmation that supplements were or were not being used, lack of direct measurements of blood vitamin levels, limitations in the variables accounted for in the final statistical model, and the interesting observation that vitamin supplementation is nearly existent in countries with much lower mortality rates like Japan.
We do recognize that the medical literature on this topic is limited and that existing studies in U.S. patients are typically small or may reflect outdated dietary or societal fortification patterns or dialysis technology. We also understand that there exists a subgroup of hemodialysis patients who are clearly at risk for vitamin deficiencies. This is why we advocate for individualization of multivitamin use. Specific conditions that would argue for vitamin supplementation include pregnancy 78 , gastric bypass surgery 79 , anorexia with poor food intake 80 , vegetarian diet or malabsorption states 81, 82 , and the use of certain medications 83, 84 . Finally, our findings should not automatically be extrapolated to hemodialysis populations outside the U.S., which have different dietary intake patterns and exposure to vitamin fortification in foodstuffs.
In summary, a review of the literature offers no strong evidence arguing for routine multivitamin supplementation in U.S. chronic hemodialysis patients. In light of the potential benefits and risks of dialysis vitamin use, we recommend that supplementation be individualized based on each patient's needs and risk profile. Further study of this topic using adequately powered and well-designed trials would be in order.
PRACTICAL APPLICATION
Multivitamin supplements are commonly provided to hemodialysis patients in the United
States. We systematically reviewed the literature and found no strong evidence for routine supplementation. We argue that supplementation should be individualized according to each patient's needs. 
